Board
The Board of Directors of the Novo Nordisk Foundation has nine members, of which six are elected under the Articles of Association and three are employee elected board members. The Board has adopted a competence profile that describes the preferred competencies of the Board.
Lars Rebien Sørensen
Chair
Lars Munch
Vice Chair
Christopher A. Voigt
Member
Jakob Müller
Member
Lars Fugger
Member
Liselotte Højgaard
Member
Mads Grøn
Member
Nana Bule Sejbæk
Member
Steen Riisgaard
Member
Stig Strøbæk
Member
Our management
Mads Krogsgaard Thomsen
CEO, Professor, DVM, PhD, DSc
Søren Nedergaard
Chief Operating Officer
Steffen P. Lüders
Senior Vice President, Corporate Affairs
Claus Felby
Senior Vice President, Biotech, Professor, PhD
Lene Oddershede
Senior Vice President, Natural & Technical Sciences, Professor
Martin Ridderstråle
Senior Vice President, Medical Science, Chief Medical Officer
Berith Bjørnholm
Senior Vice President, Education & Outreach, PhD
Peter Lawætz Andersen
Senior Vice President, Infectious Diseases, Professor, DVM, DSc
Arne Astrup
Senior Vice President, Obesity and Nutritional Sciences, professor, MD, DMSc
Thomas Alslev Christensen
Senior Vice President, Impact, PhD
Mikkel Skovborg
Senior Vice President, Innovation
Pelle Munk-Poulsen
General Counsel & Senior Vice President, Legal
Flemming Konradsen
Senior Vice President, Social & Humanitarian
Stine Fehmerling
Senior Vice President, People & Organisation
Anne Kahr Hällman
Director, Grant Management, PhD
Sofie Singbrant Söderberg
Director, Head of Project & Portfolio Management, PhD